Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Pendo in the transaction. Pendo, an all-in-one product experience platform, announced its acquisition of Zelta AI, a startup...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Solu Therapeutics in the transaction. Solu Therapeutics announced the closing of an oversubscribed $31 million seed financing co-led...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer advised Photys Therapeutics on the deal. Photys Therapeutics, a developer of phosphorylation-inducing chimeric small molecule (PHICS) medicines, announced its $75 million Series A financing...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer represented Carbon Biosciences on the deal. Carbon Biosciences, a developer of novel parvovirus-derived gene therapies, announced its emergence from stealth mode and the closing of...
You must be a Standard 1 Year member to access this content.
Fenwick and Marval, O’Farrell & Mairal represented CLEAR on the deal. Gunderson Dettmer Stough Villeneuve Franklin & Hachigian and Mitrani, Caballero & Ruiz Moreno advised Whyline....
You must be a Standard 1 Year member to access this content.
